10-K Filing

ACUTUS MEDICAL, INC. CIK: 1522860 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001564590-21-014208`
Period End Date	20201231
Filing Date	20210319
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	afib-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 41 Cash Flow Statement 85 Stockholders Equity 21

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Shares Authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.45M	USD	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$62.35M	USD	Point-in-time
Marketable securities, short-term	`MarketableSecuritiesCurrent`	$105.84M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$150.00K	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$263.00K	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$2.16M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.96M	USD	Point-in-time
Inventory	`InventoryNet`	$8.42M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.05M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.82M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$151.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$82.46M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities, long-term	`MarketableSecuritiesNoncurrent`	$8.73M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.36M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.43M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	260.00M	shares	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$2.34M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.99M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	695,902.00	shares	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$1.67M	USD	Point-in-time
Right-of-use asset, net	`OperatingLeaseRightOfUseAsset`	$3.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$4.11M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.99M	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$5.65M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	695,902.00	shares	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Goodwill	`Goodwill`	$12.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$717.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$95.00K	USD	Point-in-time
Total assets	`Assets`	$192.53M	USD	Point-in-time
Total assets	`Assets`	$105.45M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$8.27M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.88M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.31M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$10.08M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$8.20M	USD	Point-in-time
Contingent consideration, short-term	`ShorttermContingentConsideration`	$5.40M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$833.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$933.00K	USD	Point-in-time
Common and preferred stock warrant liability	`CommonAndPreferredStockWarrantLiability`	$8.92M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$31.91M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.91M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$2.05M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.13M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$39.01M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$38.24M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$3.90M	USD	Point-in-time
Contingent consideration, long-term	`LongtermContingentConsideration`	$5.70M	USD	Point-in-time
Total liabilities	`Liabilities`	$77.91M	USD	Point-in-time
Total liabilities	`Liabilities`	$65.95M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized December 31, 2020 and no shares authorized as of December 31, 2019; no shares issued and outstanding as of December 31, 2020 and 2019	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized December 31, 2020 and no shares authorized as of December 31, 2019; no shares issued and outstanding as of December 31, 2020 and 2019	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 and 220,000,000 shares authorized as of December 31, 2020 and 2019, respectively; 27,991,425 and 695,902 shares issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$28.00K	USD	Point-in-time
Common stock, $0.001 par value; 260,000,000 and 220,000,000 shares authorized as of December 31, 2020 and 2019, respectively; 27,991,425 and 695,902 shares issued and outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$33.25M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$487.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-259.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-361.01M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-30.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$280.00K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$192.53M	USD	Point-in-time
Total liabilities, convertible preferred stock and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$105.45M	USD	Point-in-time

Income Statement 41 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$8.46M	USD	Annual
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.84M	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$15.89M	USD	Annual
Cost of products sold	`CostOfGoodsAndServicesSold`	$9.24M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$23.03M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$33.45M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$26.85M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$50.36M	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$786.00K	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$97.00K	USD	Annual
Change in fair value of contingent consideration	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease`	$500.00K	USD	Annual
Total costs and operating expenses	`OperatingCostsAndExpenses`	$75.41M	USD	Annual
Total costs and operating expenses	`OperatingCostsAndExpenses`	$99.80M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-91.33M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-72.57M	USD	Annual
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$5.55M	USD	Annual
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.92M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.45M	USD	Annual
Interest income	`InterestAndOtherIncome`	$1.16M	USD	Annual
Interest income	`InterestAndOtherIncome`	$436.00K	USD	Annual
Interest expense	`InterestExpense`	$22.27M	USD	Annual
Interest expense	`InterestExpense`	$5.51M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-24.47M	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-10.62M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-101.96M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-97.04M	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	$23.00K	USD	Annual
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-97.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-101.98M	USD	Annual
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-53.00K	USD	Annual
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-96.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$363.00K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-97.09M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-101.67M	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.94	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-144.41	USD	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.41M	shares	Annual
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	671,953.00	shares	Annual

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-97.04M	USD	Annual
Net loss	`ProfitLoss`	$-101.98M	USD	Annual
Depreciation expense	`Depreciation`	$2.76M	USD	Annual
Depreciation expense	`Depreciation`	$2.28M	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$250.00K	USD	Annual
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$457.00K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$2.99M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$12.10M	USD	Annual
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$153.00K	USD	Annual
Amortization of premiums/(accretion of discounts) on marketable securities, net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-484.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$767.00K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$17.58M	USD	Annual
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$637.00K	USD	Annual
Amortization of right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$684.00K	USD	Annual
Research and development - license acquired	`ResearchAndDevelopmentInProcess`	$15.00M	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$786.00K	USD	Annual
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-1.45M	USD	Annual
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$5.55M	USD	Annual
Change in fair value of warrant liability and embedded derivative	`ChangeInFairValueOfWarrantLiabilityAndEmbeddedDerivative`	$1.92M	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$97.00K	USD	Annual
Change in fair value of contingent consideration	`ChangeInFairValueOfContingentConsideration`	$500.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.90M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.00K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$3.89M	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$5.42M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.38M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$928.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$622.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$8.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.11M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.28M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.90M	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.23M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-745.00K	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-820.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-85.17M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-55.99M	USD	Annual
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$68.73M	USD	Annual
Purchases of available-for-sale marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$114.69M	USD	Annual
Sales of available-for-sale marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$17.09M	USD	Annual
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$14.70M	USD	Annual
Maturities of available-for-sale marketable securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$45.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.40M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.22M	USD	Annual
Purchase of research and development license	`PaymentsToAcquireResearchAndDevelopmentLicense`	$10.00M	USD	Annual
Cash paid, net of cash acquired for the Rhythm Xience Acquisition	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.00M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.43M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-63.82M	USD	Annual
Proceeds from issuance of debt and warrants	`ProceedsFromIssuanceOfDebtAndWarrants`	$77.00M	USD	Annual
Repayment of debt	`ProceedsFromRepaymentsOfDebt`	$-15.00M	USD	Annual
Payment of issuance and extinguishment costs related to debt	`PaymentsOfDebtExtinguishmentCosts`	$2.33M	USD	Annual
Payment of contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$2.50M	USD	Annual
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$66.56M	USD	Annual
Proceeds from warrants exercises	`ProceedsFromWarrantExercises`	$13.00K	USD	Annual
Proceeds from issuance of common stock upon IPO, net of issuance costs	`ProceedsFromIssuanceInitialPublicOffering`	$166.29M	USD	Annual
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$634.00K	USD	Annual
Proceeds from stock options exercises	`ProceedsFromStockOptionsExercised`	$108.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$126.34M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$164.43M	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$342.00K	USD	Annual
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-96.00K	USD	Annual
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$15.78M	USD	Annual
Net change in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-173.00K	USD	Annual
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.38M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash, at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.78M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$3.59M	USD	Annual
Cash paid for interest	`InterestPaid`	$4.68M	USD	Annual
Issuance of Series D convertible preferred stock for 2018 Convertible Notes and 2019 Convertible Notes	`IssuanceOfSeriesDConvertiblePreferredStockFor2018ConvertibleNotesAnd2019ConvertibleNotes`	$68.48M	USD	Annual
Issuance of Series D convertible preferred stock for Biotronik asset purchase	`IssuanceOfSeriesDConvertiblePreferredStockForBiotroniksAssetPurchase`	$5.00M	USD	Annual
Issuance of Series D convertible preferred stock for Rhythm Xience Acquisition	`IssuanceOfSeriesDConvertiblePreferredStockForRhythmXienceAcquisition`	$2.20M	USD	Annual
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$53.00K	USD	Annual
Change in unrealized (gain) loss on marketable securities	`UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments`	$-46.00K	USD	Annual
Right-of-use assets exchanged for operating lease liabilities	`RightofuseassetsExchangedForOperatingLeaseLiabilities`	$2.98M	USD	Annual
Accrued purchase of research and development-license	`AccruedPurchaseOfResearchAndDevelopmentLicense`	$5.00M	USD	Annual
Accrued licensed intangibles assets	`AccruedLicensedIntangiblesAssets`	$2.00M	USD	Annual
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$174.00K	USD	Annual
Unpaid purchases of property and equipment	`UnpaidPurchasesOfPropertyPlantAndEquipment`	$101.00K	USD	Annual
Transfer of property and equipment to inventory	`TransferOfPropertyAndEquipmentToInventory`	$643.00K	USD	Annual
Conversion of convertible preferred stock into common stock upon IPO	`ConversionOfStockAmountConverted1`	$260.56M	USD	Annual
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	Annual

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Beginning balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-53.00K	USD	Annual
Unrealized (loss) gain on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$46.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-96.00K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$363.00K	USD	Annual
Issuance of Series D convertible preferred stock for 2018 Convertible Notes and 2019 Convertible Notes, Shares	`TemporaryEquityStockIssuedDuringPeriodSharesForConvertibleNotes`	4.11M	shares	Point-in-time
Conversion of convertible preferred stock into common stock upon IPO	`ReclassificationsOfTemporaryToPermanentEquity`	$260.56M	USD	Annual
Issuance of common stock for cash, net of issuance costs of $16,361	`StockIssuedDuringPeriodValueIssuedForServices`	$166.29M	USD	Annual
Reclassification of warrant liability to stockholders' equity	`ReclassificationOfWarrantLiabilityToStockholdersEquity`	$14.47M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$12.10M	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$2.99M	USD	Annual
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$634.00K	USD	Annual
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$108.00K	USD	Annual
Warrant exercise	`StockIssuedDuringPeriodValueWarrantsExercised`	$13.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-97.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-101.98M	USD	Annual
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-131.82M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-225.81M	USD	Point-in-time
Ending balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$126.58M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.